Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tandlægeselskabet Dentalklinikken INDRE BY ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Bankruptcy risk for industry   0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5%   Bankruptcy risk   3.3% 3.6% 2.2% 2.0% 1.7% 1.7% 10.0% 10.0%   Credit score (0-100)   56 52 65 68 72 72 25 25   Credit rating   BBB BBB BBB A A A BB BB   Credit limit (kDKK)   0.0 0.0 0.2 0.9 6.7 7.2 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   5,903 6,343 6,558 7,937 8,198 9,597 0.0 0.0   EBITDA   494 1,856 1,108 2,073 1,401 2,272 0.0 0.0   EBIT   284 1,692 1,034 2,038 1,374 2,252 0.0 0.0   Pre-tax profit (PTP)   273.2 1,672.6 1,033.4 2,028.8 1,376.6 2,234.7 0.0 0.0   Net earnings   212.6 1,296.9 803.2 1,580.3 1,073.5 1,743.0 0.0 0.0   Pre-tax profit without non-rec. items   273 1,673 1,033 2,029 1,377 2,235 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Tangible assets total   191 66.2 110 78.3 51.7 31.5 0.0 0.0   Shareholders equity total   23.0 1,320 2,123 3,703 4,777 6,520 1,440 1,440   Interest-bearing liabilities   1,604 574 504 504 504 1,518 0.0 0.0   Balance sheet total (assets)   2,514 3,608 4,506 6,088 7,760 10,114 1,440 1,440   Net Debt   1,537 454 453 410 448 1,413 -1,440 -1,440     See the entire balance sheet 1000.0 Volume  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   5,903 6,343 6,558 7,937 8,198 9,597 0.0 0.0   Gross profit growth   2.6% 7.4% 3.4% 21.0% 3.3% 17.1% -100.0% 0.0%   Employees   13 12 14 21 22 15 0 0   Employee growth %   -7.1% -7.7% 16.7% 50.0% 4.8% -31.8% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,514 3,608 4,506 6,088 7,760 10,114 1,440 1,440   Balance sheet change%   -41.9% 43.5% 24.9% 35.1% 27.5% 30.3% -85.8% 0.0%   Added value   493.9 1,855.7 1,107.9 2,072.7 1,408.8 2,272.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -394 -327 -70 -70 -53 -40 -31 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   4.8% 26.7% 15.8% 25.7% 16.8% 23.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   8.6% 55.6% 25.6% 38.5% 19.9% 25.2% 0.0% 0.0%   ROI %   12.2% 96.6% 45.9% 59.7% 29.0% 33.8% 0.0% 0.0%   ROE %   9.8% 193.1% 46.7% 54.2% 25.3% 30.9% 0.0% 0.0%   1000.0 Solidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Equity ratio %   1.0% 41.1% 49.0% 63.3% 62.7% 65.1% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   311.3% 24.5% 40.9% 19.8% 32.0% 62.2% 0.0% 0.0%   Gearing %   6,970.2% 43.5% 23.7% 13.6% 10.5% 23.3% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   1.1% 2.7% 0.8% 2.0% -0.2% 1.8% 0.0% 0.0%   1000.0 Liquidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Quick Ratio   1.0 2.3 2.2 3.5 3.0 3.3 0.0 0.0   Current Ratio   0.9 1.8 2.0 3.1 2.8 3.2 0.0 0.0   Cash and cash equivalent   66.8 120.1 50.9 93.4 55.7 105.0 0.0 0.0   1000.0 Capital use efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -265.2 1,536.4 2,180.2 4,001.7 4,956.2 6,911.7 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   38 155 79 99 64 151 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   38 155 79 99 64 151 0 0   EBIT / employee   22 141 74 97 62 150 0 0   Net earnings / employee   16 108 57 75 49 116 0 0